title: Protein-mediated adhesion of the dissimilatory Fe(III)-reducing bacterium Shewanella alga BrY to hydrous ferric oxide.
abstract: The rate and extent of bacterial Fe(III) mineral reduction are governed by molecular-scale interactions between the bacterial cell surface and the mineral surface. These interactions are poorly understood. This study examined the role of surface proteins in the adhesion of Shewanella alga BrY to hydrous ferric oxide (HFO). Enzymatic degradation of cell surface polysaccharides had no effect on cell adhesion to HFO. The proteolytic enzymes Streptomyces griseus protease and chymotrypsin inhibited the adhesion of S. alga BrY cells to HFO through catalytic degradation of surface proteins. Trypsin inhibited S. alga BrY adhesion solely through surface-coating effects. Protease and chymotrypsin also mediated desorption of adhered S. alga BrY cells from HFO while trypsin did not mediate cell desorption. Protease removed a single peptide band that represented a protein with an apparent molecular mass of 50 kDa. Chymotrypsin removed two peptide bands that represented proteins with apparent molecular masses of 60 and 31 kDa. These proteins represent putative HFO adhesion molecules. S. alga BrY adhesion was inhibited by up to 46% when cells were cultured at sub-MICs of chloramphenicol, suggesting that protein synthesis is necessary for adhesion. Proteins extracted from the surface of S. alga BrY cells inhibited adhesion to HFO by up to 41%. A number of these proteins bound specifically to HFO, suggesting that a complex system of surface proteins mediates S. alga BrY adhesion to HFO.
authors.affiliation: Department of Microbiology, University of New Hampshire, Durham, New Hampshire 03824, USA. fcj@hopper.unh.edu
authors.forename: F
authors.initials: F
authors.lastname: Caccavo
mesh_terms: D001422:Bacterial Adhesion / Q000187:drug effects; D001426:Bacterial Proteins / Q000378:metabolism*; D001673:Biodegradation, Environmental; D002462:Cell Membrane / Q000502:physiology; D002701:Chloramphenicol / Q000494:pharmacology; D002918:Chymotrypsin / Q000378:metabolism / Q000494:pharmacology; D010450:Endopeptidases / Q000378:metabolism / Q000494:pharmacology; D005290:Ferric Compounds / Q000737:chemistry / Q000378:metabolism*; D007700:Kinetics; D008565:Membrane Proteins / Q000378:metabolism*; D011135:Polysaccharides, Bacterial / Q000502:physiology*; D020592:Shewanella / Q000187:drug effects / Q000502:physiology*; D013305:Streptomyces griseus / Q000201:enzymology; D013499:Surface Properties
chemical_list: D001426:Bacterial Proteins; D005290:Ferric Compounds; D008565:Membrane Proteins; D011135:Polysaccharides, Bacterial; C000499:ferric oxide; D002701:Chloramphenicol; D010450:Endopeptidases; D002918:Chymotrypsin